Back to top

ACAD Maintained by UBS -- Price Target Raised to $49.00

ACAD Maintained by UBS -- Price Target Raised to $49.00

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ACADIA Pharmaceuticals Inc. (ACAD)